Advancing regulatory science for medical countermeasure development : workshop summary

Advancing regulatory science for medical countermeasure development workshop summary

Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community a...

Descripción completa

Detalles Bibliográficos
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation (-), Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events
Otros Autores: Wizemann, Theresa M. (-), Altevogt, Bruce M., Claiborne, Anne B.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2011.
Edición:1st ed
Materias:
Emergency management > United States > Evaluation > Congresses.
Disaster medicine > United States > Evaluation > Congresses.
Weapons of mass destruction > Health aspects > Congresses.
Chemical agents (Munitions) > Congresses.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622430606719
Tabla de Contenidos:
  • ""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 MCM Enterprise and Stakeholder Perspectives""; ""3 Cutting-Edge Efforts to Advance MCM Regulatory Science""; ""4 MCM Regulatory Science Needs for At-Risk Populations""; ""5 Crosscutting Themes and Future Directions""; ""6 Closing Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""

Ejemplares similares